BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24553912)

  • 1. GPER functions as a tumor suppressor in triple-negative breast cancer cells.
    Weißenborn C; Ignatov T; Ochel HJ; Costa SD; Zenclussen AC; Ignatova Z; Ignatov A
    J Cancer Res Clin Oncol; 2014 May; 140(5):713-23. PubMed ID: 24553912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPER functions as a tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells.
    Weißenborn C; Ignatov T; Poehlmann A; Wege AK; Costa SD; Zenclussen AC; Ignatov A
    J Cancer Res Clin Oncol; 2014 Apr; 140(4):663-71. PubMed ID: 24515910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer.
    Liu Q; Chen Z; Jiang G; Zhou Y; Yang X; Huang H; Liu H; Du J; Wang H
    Mol Cancer; 2017 May; 16(1):87. PubMed ID: 28476123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
    J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NHERF1 inhibits proliferation of triple-negative breast cancer cells by suppressing GPER signaling.
    Wang Y; Peng Z; Meng R; Tao T; Wang Q; Zhao C; Liu H; Song R; Zheng J; Qin Q; He J
    Oncol Rep; 2017 Jul; 38(1):221-228. PubMed ID: 28535016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPER Promoter Methylation Controls GPER Expression in Breast Cancer Patients.
    Weissenborn C; Ignatov T; Nass N; Kalinski T; Dan Costa S; Zenclussen AC; Ignatov A
    Cancer Invest; 2017 Feb; 35(2):100-107. PubMed ID: 28118074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells.
    Rigiracciolo DC; Santolla MF; Lappano R; Vivacqua A; Cirillo F; Galli GR; Talia M; Muglia L; Pellegrino M; Nohata N; Di Martino MT; Maggiolini M
    J Exp Clin Cancer Res; 2019 Feb; 38(1):58. PubMed ID: 30728047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.
    Skrzypczak M; Schüler S; Lattrich C; Ignatov A; Ortmann O; Treeck O
    Steroids; 2013 Nov; 78(11):1087-91. PubMed ID: 23921077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
    Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
    Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
    Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
    Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
    Li Y; Birnbaumer L; Teng CT
    Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G protein-coupled estrogen receptor 1 (GPER-1) and agonist G-1 inhibit growth of ovarian cancer cells by activation of anti-tumoral transcriptome responses: impact of GPER-1 mRNA on survival.
    Schüler-Toprak S; Skrzypczak M; Ignatov T; Ignatov A; Ortmann O; Treeck O
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3175-3188. PubMed ID: 32813115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G protein-coupled estrogen receptor 1 agonist G-1 induces cell cycle arrest in the mitotic phase, leading to apoptosis in endometriosis.
    Mori T; Ito F; Matsushima H; Takaoka O; Tanaka Y; Koshiba A; Kusuki I; Kitawaki J
    Fertil Steril; 2015 May; 103(5):1228-35.e1. PubMed ID: 25724739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyoluteorin induces cell cycle arrest and apoptosis in human triple-negative breast cancer cells MDA-MB-231.
    Ding T; Yang LJ; Zhang WD; Shen YH
    J Pharm Pharmacol; 2020 Jul; 72(7):969-978. PubMed ID: 32246778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals.
    Chen ZJ; Wei W; Jiang GM; Liu H; Wei WD; Yang X; Wu YM; Liu H; Wong CK; Du J; Wang HS
    Mol Oncol; 2016 Jun; 10(6):775-88. PubMed ID: 26842883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro.
    Han N; Heublein S; Jeschke U; Kuhn C; Hester A; Czogalla B; Mahner S; Rottmann M; Mayr D; Schmoeckel E; Trillsch F
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
    Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
    Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of G-protein coupled estrogen receptor inhibits the proliferation of cervical cancer cells via sustained activation of ERK1/2.
    Zhang Q; Wu YZ; Zhang YM; Ji XH; Hao Q
    Cell Biochem Funct; 2015 Apr; 33(3):134-42. PubMed ID: 25753185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
    Zekas E; Prossnitz ER
    BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib.
    Girgert R; Emons G; Gründker C
    Oncol Rep; 2017 Feb; 37(2):1212-1218. PubMed ID: 27959426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.